92 related articles for article (PubMed ID: 1875114)
21. Autologous bone marrow or peripheral blood stem cell transplantation for patients with chronic myelogenous leukaemia in chronic phase.
Meloni G; De Fabritiis P; Alimena G; Malagnino F; Montefusco E; Sandrelli A; Pinto R; Vignetti M; Lo Coco F; Mandelli F
Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():92-4. PubMed ID: 2576389
[TBL] [Abstract][Full Text] [Related]
22. Chronic myeloid leukemia. A perspective of the clinical and biologic issues of the chronic phase.
Silver RT
Hematol Oncol Clin North Am; 1990 Apr; 4(2):319-35. PubMed ID: 2182594
[TBL] [Abstract][Full Text] [Related]
23. Clinical studies with interferons in Philadelphia positive chronic myelogenous leukemia.
Talpaz M; Kantarjian H; Kurzrock R; Gutterman JU
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():63. PubMed ID: 2496883
[No Abstract] [Full Text] [Related]
24. [Chronic myeloid leukemia: current pathogenetic aspects and new therapeutic approaches (a foreign literature review)].
Petukhov VI; Strozha IL; Bondare DK
Ter Arkh; 2001; 73(12):96-101. PubMed ID: 11858124
[No Abstract] [Full Text] [Related]
25. [Interferon and chronic myeloid leukemia].
Steegmann JL; Pérez Sánchez M; Fernández-Rañada JM
Sangre (Barc); 1990 Jun; 35(3):213-7. PubMed ID: 2204124
[No Abstract] [Full Text] [Related]
26. [Experience with the use of reaferon (alfa 2-interferon) for treating patients with chronic myeloleukemia].
Abdulkadyrov KM; Moiseev SI; Shcherbakova EG; Balashova VA; Glazanova TV; Rukavitsyn OA; Martynkevich IS; Gritsaev SV; Blinov MN
Ter Arkh; 1995; 67(6):59-63. PubMed ID: 7667786
[TBL] [Abstract][Full Text] [Related]
27. Juvenile chronic myeloid leukaemia and alpha-interferon.
Aricò M; Nespoli L; Caselli D; Bonetti F; Porta FA; Burgio GR
Eur J Pediatr; 1989 Jan; 148(4):379-80. PubMed ID: 2707286
[No Abstract] [Full Text] [Related]
28. [Recent progress in the treatment of hematological malignancies. IV. Chronic myelocytic leukemia].
Nagi K; Kamada N
Nihon Naika Gakkai Zasshi; 1989 Jun; 78(6):792-5. PubMed ID: 2794660
[No Abstract] [Full Text] [Related]
29. Polyclonal hematopoiesis in interferon-induced cytogenetic remissions of chronic myelogenous leukemia.
Claxton D; Deisseroth A; Talpaz M; Reading C; Kantarjian H; Trujillo J; Stass S; Gooch G; Spitzer G
Blood; 1992 Feb; 79(4):997-1002. PubMed ID: 1371081
[TBL] [Abstract][Full Text] [Related]
30. CML: new biologic therapies, endpoints and questions.
Martin A; Cheson BD
Oncology (Williston Park); 1987 Sep; 1(7):12-3, 16. PubMed ID: 3152809
[No Abstract] [Full Text] [Related]
31. DNA-flow cytometry studies in blood and marrow cells from chronic myelogenous leukemia patients treated with interferon alpha-2b.
Wandl UB; May D; Peltzer T; Kloke O; Opalka B; Niederle N; Streffer C
Leuk Res; 1990; 14(10):905-8. PubMed ID: 2259227
[TBL] [Abstract][Full Text] [Related]
32. Predicting complete cytogenetic response in chronic myelogenous leukemia patients treated with recombinant interferon alpha.
Mahon FX; Montastruc M; Faberes C; Reiffers J
Blood; 1994 Nov; 84(10):3592-4. PubMed ID: 7832859
[No Abstract] [Full Text] [Related]
33. Alpha interferon dose-dependent suppression of secondary clones in a patient with Philadelphia-positive chronic myelogenous leukemia.
Claxton D; Kantarjian H; Kurzrock R; Trujillo JM; Gutterman JU; Talpaz M
Acta Haematol; 1990; 83(3):149-51. PubMed ID: 2109455
[TBL] [Abstract][Full Text] [Related]
34. Chronic myelogenous leukemia: an overview.
Bergsagel DE
J Cancer Res Clin Oncol; 1990; 116(1):104-5. PubMed ID: 2312599
[No Abstract] [Full Text] [Related]
35. [A comparative analysis of the effect of alpha 2-interferon (reaferon) therapy on the morphofunctional state of the bone marrow in patients with chronic myeloleukemia].
Abdulkadyrov KM; Rukavitsyn OA; Moiseev SI; Rugal' VI
Gematol Transfuziol; 1993 Mar; 38(3):11-3. PubMed ID: 8020725
[TBL] [Abstract][Full Text] [Related]
36. [Therapeutic prospects of interferon in patients with chronic myelocytic leukemia].
Podsiadło Z; Skotnicki AB; Blicharski J
Przegl Lek; 1988; 45(9):687-9. PubMed ID: 3075051
[No Abstract] [Full Text] [Related]
37. Elimination by interferon-alpha of malignant clone in chronic myeloid leukaemia.
Opalka B; Kloke O; Bartram CR; Beer U; Janssen JW; Niederle N; Wandl UB
Lancet; 1989 Jun; 1(8650):1334. PubMed ID: 2566865
[No Abstract] [Full Text] [Related]
38. Activity of alpha-interferons in chronic myelogenous leukaemia.
Talpaz M
Br J Clin Pract Suppl; 1988 Mar; 62():13-5. PubMed ID: 3145008
[No Abstract] [Full Text] [Related]
39. Anti-interferon antibodies in alpha interferon treated patients with chronic myeloid leukaemia.
Aitchison R; Allen P; Schey S; Newland AC
Br J Haematol; 1991 Jul; 78(3):465-7. PubMed ID: 1873235
[No Abstract] [Full Text] [Related]
40. Interferon in the treatment of chronic myeloid leukemia. Proceedings of a workshop. February 4-7, 1993, Flims, Switzerland.
Semin Hematol; 1993 Jul; 30(3 Suppl 3):1-54. PubMed ID: 8235695
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
